Results for tag: "Colorectal Metastasis Drug"

The Colorectal Metastasis Drug market is a subset of the larger Colon Cancer Drugs market. It focuses on drugs that are used to treat metastatic colorectal cancer, which is cancer that has spread from the colon or rectum to other parts of the body. These drugs are typically used in combination with other treatments such as chemotherapy, radiation, and surgery. Common drugs used to treat metastatic colorectal cancer include bevacizumab, cetuximab, and panitumumab. These drugs work by targeting specific proteins on the surface of cancer cells, which helps to slow or stop the growth of the cancer. Some of the major companies in the Colorectal Metastasis Drug market include Roche, Merck, Pfizer, AstraZeneca, and Bristol-Myers Squibb. These companies are involved in the research, development, and marketing of drugs used to treat metastatic colorectal cancer. Show Less Read more